Literature DB >> 6251114

Inhibitory action of a met-enkephalin on ACTH release in man.

E del Pozo, J Martin-Perez, A Stadelmann, J Girard, J Brownell.   

Abstract

In order to study the mechanism of action of a Met-enkephalin (FK 33824) on the pituitary-adrenal axis eight normal male volunteers were subjected to an ACTH stimulation test. Lysine-vasopressing (LVP), 5 IU, was injected intramuscularly after pretreatment with 0.5 mg FK 33824 i.m. or a placebo. In six of the subjects the opiate was again administered preceding a single injection of 0.25 mg ACTH beta 1-24 i.m. Blood was collected at regular intervals and ACTH and cortisol concentrations analyzed in all samples. LVP induced significant plasma ACTH (P < 0.05) and cortisol (P < 0.001) increases. Pretreatment with FK 33824 completely antagonized the effect of LVP. Furthermore, the cortisol elevation after exogenous ACTH was not modified by previous administration of FK 33824. It is concluded that the Met-enkephalin derivative FK 33824 directly suppresses ACTH release from the pituitary without influencing adrenal synthesis of cortisol.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6251114      PMCID: PMC371494          DOI: 10.1172/JCI109820

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  9 in total

1.  Opiate receptor binding in the pituitary gland.

Authors:  R Simantov; S H Snyder
Journal:  Brain Res       Date:  1977-03-18       Impact factor: 3.252

2.  A synthetic enkephalin analogue with prolonged parenteral and oral analgesic activity.

Authors:  D Roemer; H H Buescher; R C Hill; J Pless; W Bauer; F Cardinaux; A Closse; D Hauser; R Huguenin
Journal:  Nature       Date:  1977-08-11       Impact factor: 49.962

3.  Enkephalin-induced inhibition of cortical neurones and the lack of this effect in morphine tolerant/dependent rats.

Authors:  W Zieglgänsberger; J P Fry; A Herz; L Moroder; E Wünsch
Journal:  Brain Res       Date:  1976-10-08       Impact factor: 3.252

4.  Rat brain enkephalins: distribution and biosynthesis.

Authors:  H Y Yang; J S Hong; W Fratta; E Costa
Journal:  Adv Biochem Psychopharmacol       Date:  1978

5.  Effects of the synthetic enkephalin analogue FK 33-824 in man.

Authors:  B von Graffenried; E del Pozo; J Roubicek; E Krebs; W Poldinger; P Burmeister; L Kerp
Journal:  Nature       Date:  1978-04-20       Impact factor: 49.962

6.  Effects of morphine on serum growth hormone, cortisol, prolactin and thyroid stimulating hormone in man.

Authors:  G Tolis; J Hickey; H Guyda
Journal:  J Clin Endocrinol Metab       Date:  1975-10       Impact factor: 5.958

7.  Endogenous opioid peptides: multiple agonists and receptors.

Authors:  J A Lord; A A Waterfield; J Hughes; H W Kosterlitz
Journal:  Nature       Date:  1977-06-09       Impact factor: 49.962

8.  Corticotrophin releasing activity in extracts of the stalk median eminence of Brattleboro rats.

Authors:  G Gillies; P J Lowry
Journal:  J Endocrinol       Date:  1980-01       Impact factor: 4.286

9.  Hormonal and metabolic responses to an enkephalin analogue in normal man.

Authors:  W A Stubbs; G Delitala; A Jones; W J Jeffcoate; C R Edwards; S J Ratter; G M Besser; S R Bloom; K G Alberti
Journal:  Lancet       Date:  1978-12-09       Impact factor: 79.321

  9 in total
  3 in total

1.  Effects of synthetic adrenocorticotrophin on adrenal medullary responses to splanchnic nerve stimulation in conscious calves.

Authors:  A V Edwards; D Hansell; C T Jones
Journal:  J Physiol       Date:  1986-10       Impact factor: 5.182

2.  Analgesic, central, cardiovascular and endocrine effects of the enkephalin analogue Tyr-D.Arg-Gly-Phe(4NO2)-Pro-NH2 (443C81) in healthy volunteers.

Authors:  J Posner; S G Moody; A W Peck; D Rutter; A Telekes
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

3.  Effect of naloxone on counter insulin hormone secretion in insulin-induced hypoglycemia.

Authors:  Y S Ju; S W Kim; I M Yang; J W Kim; Y S Kim; Y K Choi
Journal:  Korean J Intern Med       Date:  1987-07       Impact factor: 2.884

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.